A single-center retrospective study in China found a significant association between pain duration and intensity in patients ...

Treatment with XG005 resulted in statistically significant and clinically meaningful reduction in post-surgical pain ...

BHV-2100 is under clinical development by Biohaven and currently in Phase II for Neuropathic Pain (Neuralgia).

Neuropathic Pain Drugs Found to Increase Risk of Hip Fracture in Older Adults Nov. 13, 2024 — A new study by medicine safety experts found the use of gabapentinoids -- medicines widely used to ...

CFTX-1554 is under clinical development by Eli Lilly and Co and currently in Phase I for Peripheral Neuropathic Pain.